These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 12970733

  • 21. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV, Sanderson H, Partin AW, Epstein JI.
    J Urol; 2002 Jun; 167(6):2440-2. PubMed ID: 11992053
    [Abstract] [Full Text] [Related]

  • 22. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 23. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
    Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, Scattoni V, Friedrich MG, Schlomm T, Haese A, Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI.
    BJU Int; 2006 Aug 01; 98(2):329-34. PubMed ID: 16879673
    [Abstract] [Full Text] [Related]

  • 24. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH.
    Eur Urol; 2007 Apr 01; 51(4):931-9. PubMed ID: 16935413
    [Abstract] [Full Text] [Related]

  • 25. Is prostate-specific antigen (PSA) density better than the preoperative PSA level in predicting early biochemical recurrence of prostate cancer after radical prostatectomy?
    Jones TD, Koch MO, Bunde PJ, Cheng L.
    BJU Int; 2006 Mar 01; 97(3):480-4. PubMed ID: 16469012
    [Abstract] [Full Text] [Related]

  • 26. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 01; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 27. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
    Chun FK, Steuber T, Erbersdobler A, Currlin E, Walz J, Schlomm T, Haese A, Heinzer H, McCormack M, Huland H, Graefen M, Karakiewicz PI.
    Eur Urol; 2006 May 01; 49(5):820-6. PubMed ID: 16439050
    [Abstract] [Full Text] [Related]

  • 28. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 29. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K.
    Int J Urol; 2007 Aug 01; 14(8):713-8. PubMed ID: 17681061
    [Abstract] [Full Text] [Related]

  • 30. Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy.
    Patel DA, Presti JC, McNeal JE, Gill H, Brooks JD, King CR.
    J Clin Oncol; 2005 Sep 01; 23(25):6157-62. PubMed ID: 16135482
    [Abstract] [Full Text] [Related]

  • 31. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
    Chun FK, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E, Walz J, Roehrborn CG, Salonia A, Rigatti P, Saad F, Huland H, Montorsi F, Graefen M, Karakiewicz PI.
    Eur Urol; 2007 Oct 01; 52(4):1067-74. PubMed ID: 17383807
    [Abstract] [Full Text] [Related]

  • 32. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
    Sim HG, Telesca D, Culp SH, Ellis WJ, Lange PH, True LD, Lin DW.
    J Urol; 2008 May 01; 179(5):1775-9. PubMed ID: 18343432
    [Abstract] [Full Text] [Related]

  • 33. The maximum tumour length in biopsy cores as a predictor of outcome after radical prostatectomy.
    Hayashi N, Urashima M, Kuruma H, Arai Y, Kuwao S, Iwamura M, Egawa S.
    BJU Int; 2008 Jan 01; 101(2):175-80. PubMed ID: 17850362
    [Abstract] [Full Text] [Related]

  • 34. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 35. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
    Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR.
    J Urol; 2001 Oct 01; 166(4):1322-7. PubMed ID: 11547066
    [Abstract] [Full Text] [Related]

  • 36. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct 01; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 37. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Oct 01; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 38. Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
    Richstone L, Bianco FJ, Shah HH, Kattan MW, Eastham JA, Scardino PT, Scherr DS.
    BJU Int; 2008 Mar 01; 101(5):541-6. PubMed ID: 18257855
    [Abstract] [Full Text] [Related]

  • 39. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM, Koch MO, Eble JN, Lin H, Cheng L.
    J Urol; 2006 May 01; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [Abstract] [Full Text] [Related]

  • 40. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr 01; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.